Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy

Journal of Biomedical Optics

Volumn 15, Issue 1, 2010, Pages

  Bhuvaneswari, Ramaswamy ^a   Thong, Patricia S P ^a   Gan, Yik Yuen ^b   Soo, Khee Chee ^a   Olivo, Malini ^a,c,d  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c AGENCY FOR SCIENCE   (Singapore)

^d NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Angiogenesis; Bevacizumab; Blood vessel analysis; Fluorescence imaging; Laser confocal endomicroscopy; Photodynamic therapy

Indexed keywords

ANGIOGENESIS; ANGIOGENESIS INHIBITORS; ANTIANGIOGENIC; ANTIANGIOGENIC AGENT; BEVACIZUMAB; BLADDER CARCINOMA; COMBINATION THERAPY; CONFOCAL FLUORESCENCE; CROSS SECTIONAL AREA; FLUORESCENCE IMAGING; IMMUNOHISTOCHEMISTRY; IN-VIVO; LOCALIZED TREATMENT; POST TREATMENT; PRECLINICAL STUDIES; THERAPEUTIC INTERVENTION; TUMOR ANGIOGENESIS; TUMOR REGRESSION; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULATURE;

BLOOD; BLOOD VESSELS; DISEASES; FLUORESCENCE; MAMMALS; MONOCLONAL ANTIBODIES; PHOTOSENSITIZERS; PLASMONS; TUMORS; VISUALIZATION;

PHOTODYNAMIC THERAPY;

MUS;

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; DRUG DERIVATIVE; HYPERICIN; MONOCLONAL ANTIBODY; PERYLENE; RADIOSENSITIZING AGENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE; VASCULOTROPIN A;

ANIMAL; ANOXIA; ARTICLE; BAGG ALBINO MOUSE; CONFOCAL MICROSCOPY; DRUG SCREENING; EXPERIMENTAL NEOPLASM; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; METHODOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHOTOCHEMOTHERAPY; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANOXIA; ANTIBODIES, MONOCLONAL; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PERYLENE; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77953171424     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3281671     Document Type: Article

References (40)

1. D. E. Dolmans, D. Fukumura, and R. K. Jain, "Photodynamic therapy for cancer", Nat. Rev. Cancer 3(5), 380-387 (2003). (Pubitemid 37328858)
2. I. J. Macdonald and T. J. Dougherty, "Basic principles of photodynamic therapy", J. Porphyr. Phthalocyanines 5, 105-129 (2001). (Pubitemid 32125231)
3. A. P. Castano, P. Mroz, and M. R. Hamblin, "Photodynamic therapy and anti-tumour immunity", Nat. Rev. Cancer 6(7), 535-545 (2006). (Pubitemid 43980542)
4. B. W. Henderson and V. H. Fingar, "Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor", Cancer Res. 47(12), 3110-3114 (1987). (Pubitemid 17082632)
5. J. Folkman, "Role of angiogenesis in tumor growth and metastasis", Semin. Oncol. 29(6, Suppl. 16), 15-18 (2002).
6. N. Ferrara, "Role of vascular endothelial growth factor in the regulation of angiogenesis", Kidney Int. 56(3), 794-814 (1999). (Pubitemid 29411709)
7. Z. M. Shao and M. Nguyen, "Angiogenic factors and bladder cancer", Front. Biosci. 7, e33-35 (2002).
8. C. C. Yang, K. C. Chu, and W. M. Yeh, "The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression", Semin Urol. Oncol. 22(1), 1-6 (2004).
9. H. Sasano and T. Suzuki, "Pathological evaluation of angiogenesis in human tumor", Biomed. Pharmacother 59(Suppl. 2), S334-336 (2005).
10. R. Bhuvaneswari, Y. Y. Gan, K. K. Yee, K. C. Soo, and M. Olivo, "Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma", Int. J. Mol. Med. 20(4), 421-428 (2007).
11. A. Ferrario and C. J. Gomer, "Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model", J. Environ. Pathol. Toxicol. Oncol. 25(1-2), 251-259 (2006). (Pubitemid 43341245)
12. M. Uehara, T. Inokuchi, K. Sano, and W. ZuoLin, "Expression of vascular endothelial growth factor in mouse tumours subjected to photodynamic therapy", Eur. J. Cancer 37(16), 2111-2115 (2001). (Pubitemid 32938117)
13. K. K. Yee, K. C. Soo, and M. Olivo, "Anti-angiogenic effects of hypericin-photodynamic therapy in combination with Celebrex in the treatment of human nasopharyngeal carcinoma", Int. J. Mol. Med. 16(6), 993-1002 (2005).
14. J. M. Davies and R. M. Goldberg, "First-line therapeutic strategies in metastatic colorectal cancer", Oncology 22(13), 1470-1479 (2008).
15. Y. Fujita, R. Abe, and H. Shimizu, "Clinical approaches toward tumor angiogenesis: past, present and future", Curr. Pharm. Des. 14(36), 3820-3834 (2008).
16. T. Shih and C. Lindley, "Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies", Clin. Ther. 28(11), 1779-1802 (2006). (Pubitemid 46038527)
17. A. Ferrario, K. F. von Tiehl, N. Rucker, M. A. Schwarz, P. S. Gill, and C. J. Gomer, "Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma", Cancer Res. 60(15), 4066-4069 (2000). (Pubitemid 30636586)
18. N. Charnley, S. Donaldson, and P. Price, "Imaging angiogenesis", Methods Mol. Biol. 467, 25-51 (2009).
19. D. Fukumura and R. K. Jain, "Imaging angiogenesis and the microenvironment", APMIS 116(7-8), 695-715 (2008).
20. P. S. Thong, M. Olivo, K. W. Kho, W. Zheng, K. Mancer, M. Harris, and K. C. Soo, "Laser confocal endomicroscopy as a novel technique for fluorescence diagnostic imaging of the oral cavity", J. Biomed. Opt. 12(1), 014007 (2007).
21. H. Liu, Y. Q. Li, T. Yu, Y. A. Zhao, J. P. Zhang, J. N. Zhang, Y. T. Guo, X. J. Xie, T. G. Zhang, and P. V. Desmond, "Confocal endomicroscopy for in vivo detection of microvascular architecture in normal and malignant lesions of upper gastrointestinal tract", J. Gastroenterol. Hepatol 23(1), 56-61 (2008). (Pubitemid 350265206)
22. R. Bhuvaneswari, G. Y. Yuen, S. K. Chee, and M. Olivo, "Hypericinmediated photodynamic therapy in combination with Avastin (bevacizumab) improves tumor response by downregulating angiogenic proteins", Photochem. Photobiol. Sci. 6(12), 1275-1283 (2007). (Pubitemid 350191102)
23. R. Bhuvaneswari, Y. Y. Gan, K. C. Soo, and M. Olivo, "The effect of photodynamic therapy on angiogenesis", Cell. Mol. Life Sci. 66(14), 2275-2283 (2009).
24. B. W. Henderson, S. O. Gollnick, J. W. Snyder, T. M. Busch, P. C. Kousis, R. T. Cheney, and J. Morgan, "Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors", Cancer Res. 64(6), 2120-2126 (2004). (Pubitemid 38339462)
25. H. W. Wang, M. E. Putt, M. J. Emanuele, D. B. Shin, E. Glatstein, A. G. Yodh, and T. M. Busch, "Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome", Cancer Res. 64(20), 7553-7561 (2004). (Pubitemid 39372100)
26. E. R. de Haas, B. Kruijt, H. J. Sterenborg, H. A. Martino Neumann, and D. J. Robinson, "Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy", J. Invest. Dermatol. 126(12), 2679-2686 (2006). (Pubitemid 44764052)
27. R. Bhuvaneswari, Y. Y. Gan, S. S. Lucky, W. W. Chin, S. M. Ali, K. C. Soo, and M. Olivo, "Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy", Mol. Cancer 7, 56 (2008).
28. P. S. Thong, F. Watt, M. Q. Ren, P. H. Tan, K. C. Soo, and M. Olivo, "Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT", Photochem. Photobiol. Sci. 82(1), 1-8 (2006). (Pubitemid 43019626)
29. C. J. Gomer, A. Ferrario, M. Luna, N. Rucker, and S. Wong, "Photodynamic therapy: combined modality approaches targeting the tumor microenvironment", Lasers Surg. Med. 38(5), 516-521 (2006).
30. C. Lu, A. A. Kamat, Y. G. Lin, W. M. Merritt, C. N. Landen, T. J. Kim, W. Spannuth, T. Arumugam, L. Y. Han, N. B. Jennings, C. Logsdon, R. B. Jaffe, R. L. Coleman, and A. K. Sood, "Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma", Clin. Cancer Res. 13(14), 4209-4217 (2007). (Pubitemid 47105985)
31. A. Hoffman, M. Goetz, M. Vieth, P. R. Galle, M. F. Neurath, and R. Kiesslich, "Confocal laser endomicroscopy: technical status and current indications", Endoscopy 38(12), 1275-1283 (2006). (Pubitemid 44964055)
32. H. Liu, Y. Q. Li, T. Yu, Y. A. Zhao, J. P. Zhang, X. L. Zuo, C. Q. Li, J. N. Zhang, Y. T. Guo, and T. G. Zhang, "Confocal laser endomicroscopy for superficial esophageal squamous cell carcinoma", Endoscopy 41(2), 99-106 (2009).
33. R. W. Leong, N. Q. Nguyen, C. G. Meredith, S. Al-Sohaily, D. Kukic, P. M. Delaney, E. R. Murr, J. Yong, N. D. Merrett, and A. V. Biankin, "In vivo confocal endomicroscopy in the diagnosis and evaluation of celiac disease", Gastroenterology 135(6), 1870-1876 (2008).
34. M. Goetz, S. Thomas, A. Heimann, P. Delaney, C. Schneider, M. Relle, A. Schwarting, P. R. Galle, O. Kempski, M. F. Neurath, and R. Kiesslich, "Dynamic imaging of microvasculature and perfusion by miniaturized confocal laser microscopy", Eur. Surg. Res. 41(3), 290-297 (2008).
35. D. Fukumura and R. K. Jain, "Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization", Microvasc. Res. 74(2-3), 72-84 (2007). (Pubitemid 350051025)
36. D. G. Duda, T. T. Batchelor, C. G. Willett, and R. K. Jain, "VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects", Trends Mol. Med. 13(6), 223-230 (2007). (Pubitemid 46836870)
37. R. K. Jain, "Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy", Science 307(5706), 58-62 (2005). (Pubitemid 40093472)
38. R. K. Jain, R. T. Tong, and L. L. Munn, "Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model", Cancer Res. 67(6), 2729-2735 (2007). (Pubitemid 46548961)
39. H. Saito, S. Tsujitani, A. Kondo, M. Ikeguchi, M. Maeta, and N. Kaibara, "Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinoma", Surgery (St. Louis) 125(2), 195-201 (1999). (Pubitemid 29076116)
40. M. Nakamura, H. Yamabe, H. Osawa, N. Nakamura, M. Shimada, R. Kumasaka, R. Murakami, T. Fujita, T. Osanai, and K. Okumura, "Hypoxic conditions stimulate the production of angiogenin and vascular endothelial growth factor by human renal proximal tubular epithelial cells in culture", Nephrol. Dial Transplant 21(6), 1489-1495 (2006). (Pubitemid 44063122)